Register for our free email digests:
Latest From Novagali Pharma SA
Plus news on recent financial activity by Mersana Therapeutics, Hyperion Therapeutics, Atterocor and Exelixis.
Plus news on recent financings by Genkyotex, Synageva, Nektar Therapeutics and Edmond de Rothschild Investment Partners.
Four years after closing the BioDiscovery 3 at €156 million, Edmond de Rothschild Investment Partners is now on the road raising a €200 million fourth fund to invest innovative European life sciences companies. The French venture capitalist started fundraising three weeks ago and is confident that it will be able to complete a first closing at more than €100 million by the end of April or early May.
French drug delivery company, Adocia, raises $33 million to develop new formulations of therapeutic proteins for wound healing, diabetes
- Surgical Equipment & Devices
- Therapeutic Areas
- North America
- Parent & Subsidiaries
- Rhytec Inc.
- Senior Management
Mark Goble, MD, CEO
Ken Grant, VP, Mktg. & Bus. Dev.
- Contact Info
Phone: (781) 290-0545
1000 Winter St.
Waltham, MA 02451
You must sign in to use this functionality
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.